ATE484509T1 - Antibakterielle mittel - Google Patents
Antibakterielle mittelInfo
- Publication number
- ATE484509T1 ATE484509T1 AT05782987T AT05782987T ATE484509T1 AT E484509 T1 ATE484509 T1 AT E484509T1 AT 05782987 T AT05782987 T AT 05782987T AT 05782987 T AT05782987 T AT 05782987T AT E484509 T1 ATE484509 T1 AT E484509T1
- Authority
- AT
- Austria
- Prior art keywords
- antibacterial agents
- quinoxaline
- quinoline
- mammals
- naphthalene
- Prior art date
Links
- 239000003242 anti bacterial agent Substances 0.000 title 1
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 abstract 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 abstract 2
- XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 150000005054 naphthyridines Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59818004P | 2004-08-02 | 2004-08-02 | |
| PCT/US2005/027348 WO2006017468A2 (en) | 2004-08-02 | 2005-08-02 | Antibacterial agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE484509T1 true ATE484509T1 (de) | 2010-10-15 |
Family
ID=35839845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05782987T ATE484509T1 (de) | 2004-08-02 | 2005-08-02 | Antibakterielle mittel |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7655648B2 (enExample) |
| EP (1) | EP1781669B1 (enExample) |
| JP (1) | JP2008508359A (enExample) |
| AT (1) | ATE484509T1 (enExample) |
| DE (1) | DE602005024151D1 (enExample) |
| WO (1) | WO2006017468A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7263501B2 (en) | 2003-03-11 | 2007-08-28 | I-Stat Corporation | Point-of-care inventory management system and method |
| EP1845995A4 (en) * | 2005-01-25 | 2010-03-03 | Glaxo Group Ltd | ANTIBACTERIAL AGENTS |
| US8217042B2 (en) | 2005-11-11 | 2012-07-10 | Zentaris Gmbh | Pyridopyrazines and their use as modulators of kinases |
| EP1790342A1 (de) | 2005-11-11 | 2007-05-30 | Zentaris GmbH | Pyridopyrazin-Derivate und deren Verwendung als Modulatoren der Signaltransduktionswege |
| JP2009532423A (ja) | 2006-04-06 | 2009-09-10 | グラクソ グループ リミテッド | 抗菌剤としてのピロロ−キノキサリノン誘導体 |
| EP2007377A4 (en) | 2006-04-06 | 2011-08-17 | Glaxo Group Ltd | ANTIBACTERIAL ACTIVE SUBSTANCES |
| KR101409261B1 (ko) | 2006-05-26 | 2014-06-18 | 다이쇼 세이야꾸 가부시끼가이샤 | 신규의 복소환 화합물 또는 그 염 및 그 중간체 |
| EP1992628A1 (en) | 2007-05-18 | 2008-11-19 | Glaxo Group Limited | Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones |
| JP5389013B2 (ja) * | 2007-04-20 | 2014-01-15 | グラクソ グループ リミテッド | 抗菌剤としての三環式含窒素化合物 |
| EP2080761A1 (en) | 2008-01-18 | 2009-07-22 | Glaxo Group Limited | Compounds |
| JP2012505866A (ja) | 2008-10-17 | 2012-03-08 | グラクソ グループ リミテッド | 抗菌剤として使用される三環式窒素化合物 |
| WO2010081874A1 (en) | 2009-01-15 | 2010-07-22 | Glaxo Group Limited | Naphthyridin-2 (1 h)-one compounds useful as antibacterials |
| AU2015304847B2 (en) | 2014-08-22 | 2018-10-25 | Glaxosmithkline Intellectual Property Development Limited | Tricyclic nitrogen containing compounds for treating Neisseria gonorrhoea infection |
| UY36851A (es) | 2015-08-16 | 2017-03-31 | Glaxosmithkline Ip Dev Ltd | Compuestos para uso en aplicaciones antibacterianas |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2634483B2 (fr) * | 1987-12-29 | 1994-03-04 | Esteve Labor Dr | Derives des acides 7-(1-azetidinyl)-1,4-dihydro-4-oxoquinoleine-3-carboxyliques, leur preparation et leur application en tant que medicaments |
| US5162523A (en) * | 1989-07-21 | 1992-11-10 | Hoffmann-La Roche Inc. | Cephalosporin antibacterial compounds |
| DE60125373T2 (de) | 2000-07-26 | 2007-10-18 | Smithkline Beecham P.L.C., Brentford | Aminopiperidin chinoline und ihre azaisosteren analoga mit antibakterieller wirkung |
| GB0101577D0 (en) | 2001-01-22 | 2001-03-07 | Smithkline Beecham Plc | Compounds |
| WO2003064421A1 (en) | 2002-01-29 | 2003-08-07 | Glaxo Group Limited | Aminopiperidine derivatives |
| AU2003239302A1 (en) | 2002-01-29 | 2003-09-02 | Glaxo Group Limited | Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them |
| US6995144B2 (en) | 2002-03-14 | 2006-02-07 | Eisai Co., Ltd. | Nitrogen containing heterocyclic compounds and medicines containing the same |
| AR040336A1 (es) | 2002-06-26 | 2005-03-30 | Glaxo Group Ltd | Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto |
| AU2003300952A1 (en) | 2002-12-13 | 2004-07-09 | Smithkline Beecham Corporation | Indane compounds as ccr5 antagonists |
| AR042486A1 (es) | 2002-12-18 | 2005-06-22 | Glaxo Group Ltd | Compuesto de quinolina y naftiridina halosustituido en la posicion 3, procedimiento para preparar el compuesto, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion . |
| TW200507841A (en) | 2003-03-27 | 2005-03-01 | Glaxo Group Ltd | Antibacterial agents |
| WO2004092177A1 (en) | 2003-04-09 | 2004-10-28 | Biogen Idec Ma Inc. | Triazolopyrazines and methods of making and using the same |
| US7550485B2 (en) | 2003-10-14 | 2009-06-23 | Wyeth | Substituted N-heterocycle derivatives and methods of their use |
| US7691850B2 (en) | 2004-06-15 | 2010-04-06 | Glaxo Group Limited | Antibacterial agents |
| EP1773343A4 (en) * | 2004-07-13 | 2009-05-13 | Glaxo Group Ltd | ANTIBACTERIAL AGENTS |
| US20070161627A1 (en) * | 2004-08-09 | 2007-07-12 | Miller William H | Antibacterial agents |
-
2005
- 2005-08-02 AT AT05782987T patent/ATE484509T1/de not_active IP Right Cessation
- 2005-08-02 US US11/572,929 patent/US7655648B2/en not_active Expired - Fee Related
- 2005-08-02 EP EP05782987A patent/EP1781669B1/en not_active Expired - Lifetime
- 2005-08-02 DE DE602005024151T patent/DE602005024151D1/de not_active Expired - Lifetime
- 2005-08-02 WO PCT/US2005/027348 patent/WO2006017468A2/en not_active Ceased
- 2005-08-02 JP JP2007524898A patent/JP2008508359A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20070244091A1 (en) | 2007-10-18 |
| JP2008508359A (ja) | 2008-03-21 |
| US7655648B2 (en) | 2010-02-02 |
| WO2006017468A3 (en) | 2006-07-13 |
| EP1781669A2 (en) | 2007-05-09 |
| EP1781669A4 (en) | 2009-03-11 |
| DE602005024151D1 (de) | 2010-11-25 |
| EP1781669B1 (en) | 2010-10-13 |
| WO2006017468A2 (en) | 2006-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60334016D1 (de) | Antibakterielle mittel | |
| TW200507841A (en) | Antibacterial agents | |
| WO2006002047A3 (en) | Antibacterial agents | |
| WO2004058144A3 (en) | Antibacterial agents | |
| DE60331849D1 (de) | Antibakterielle wirkstoffe | |
| ATE344799T1 (de) | Piperidinderivate als antibakterielle mittel | |
| WO2006020561A3 (en) | Antibacterial agents | |
| WO2007016610A3 (en) | Antibacterial agents | |
| WO2007118130A3 (en) | Antibacterial agents | |
| PE20001112A1 (es) | Derivados de quinolina como agentes antibacterianos | |
| WO2006081289A3 (en) | Antibacterial agents | |
| AU2003251474A8 (en) | Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity | |
| ATE255104T1 (de) | Quinolin-derivate und deren verwendung als antibakterielle wirkstoffe | |
| ATE484509T1 (de) | Antibakterielle mittel | |
| DE602004021644D1 (de) | Gyraseinhibitoren und deren verwendungen | |
| WO2006010040A3 (en) | Antibacterial agents | |
| DE60324179D1 (de) | Chinoline und stickstoffhaltige derivatedavon und deren verwendung als antibakterielle mittel | |
| NO20052362D0 (no) | Fremgangsmater for administrering av dalbavancin for behandling av bakterielle infeksjoner | |
| ATE354585T1 (de) | Antibakterielle amid-makrozyklen | |
| WO2006081182A3 (en) | Antibacterial agents | |
| NO20072890L (no) | Behandling av mastitt | |
| WO2006081178A3 (en) | Antibacterial agents | |
| ATE495186T1 (de) | Antibakterielle amid-makrozyklen iv | |
| ATE433459T1 (de) | Desoxo-nonadepsipeptide | |
| WO2005118613A3 (de) | Antibakterielle amid-makrozyklen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |